Please login to the form below

Not currently logged in
Email:
Password:

Bruce Peacock joins Dicerna from Ophthotech

He is appointed to its board of directors and audit committee

edit-Bruce-Peacock_2014US-based biopharma company Dicerna Pharmaceuticals has appointed Bruce Peacock to its board of directors and audit committee.

He joins from Ophthotech where he served since 2010, most recently as its chief financial and business officer and prior to that, his previous roles include serving as chief operating officer of Cephalon and chief financial officer of Centocor.

Massachusetts-headquartered Dicerna develops RNAi-based therapeutics with a focus on the discovery and development of treatments for rare inherited diseases involving the liver and for cancers that are genetically defined.

Douglas Fambrough, CEO at Dicerna, said: “Bruce Peacock is a recognised leader in the biotech industry. With an impressive list of accomplishments in operations, management and business development, Bruce will be a terrific addition to our board.”

22nd September 2014

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Mednet Group

Communique Small consultancy of the year 2020. With diversity and inclusion at our core, Mednet Group consists of Attigo CIC...

Latest intelligence

Personalised medicine AI
How early-stage clinical research is facilitating the new wave of personalised medicines
By Jorg Taubel...
patient diversity buckland
Patient diversity in clinical trials needs to be centre stage
By Danny Buckland...
Why empathy in digital patient recruitment is vital
This is where empathy mapping can be incredibly effective....